HK1024695A1 - Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them - Google Patents

Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them

Info

Publication number
HK1024695A1
HK1024695A1 HK00104036A HK00104036A HK1024695A1 HK 1024695 A1 HK1024695 A1 HK 1024695A1 HK 00104036 A HK00104036 A HK 00104036A HK 00104036 A HK00104036 A HK 00104036A HK 1024695 A1 HK1024695 A1 HK 1024695A1
Authority
HK
Hong Kong
Prior art keywords
camptothecin
counterparts
medicine
novel
application
Prior art date
Application number
HK00104036A
Inventor
Dennis Bigg
Olivier Lavergne
Rodas Francesc Pla
Jacques Pommier
Gerard Ulibarri
Original Assignee
S C R A S Soc De Conseils De R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S C R A S Soc De Conseils De R filed Critical S C R A S Soc De Conseils De R
Publication of HK1024695A1 publication Critical patent/HK1024695A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK00104036A 1996-12-20 2000-07-04 Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them HK1024695A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9615774A FR2757514B1 (en) 1996-12-20 1996-12-20 NOVEL CAMPTOTHECIN ANALOGS, PREPARATION METHODS, USE THEREOF AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PCT/FR1997/002218 WO1998028305A1 (en) 1996-12-20 1997-12-05 Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
HK1024695A1 true HK1024695A1 (en) 2000-10-20

Family

ID=9498938

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00104036A HK1024695A1 (en) 1996-12-20 2000-07-04 Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them

Country Status (26)

Country Link
EP (1) EP0946567B1 (en)
JP (2) JP3576175B2 (en)
KR (1) KR100516874B1 (en)
CN (1) CN1097056C (en)
AR (1) AR008543A1 (en)
AT (1) ATE248177T1 (en)
AU (1) AU734485B2 (en)
BR (1) BR9714170A (en)
CA (1) CA2275351C (en)
CZ (1) CZ299795B6 (en)
DE (1) DE69724453T2 (en)
DK (1) DK0946567T3 (en)
ES (1) ES2206761T3 (en)
FR (1) FR2757514B1 (en)
HK (1) HK1024695A1 (en)
HU (1) HUP9904210A3 (en)
MX (1) MXPA99005776A (en)
MY (1) MY119473A (en)
NO (1) NO326464B1 (en)
NZ (1) NZ335939A (en)
PL (1) PL188181B1 (en)
PT (1) PT946567E (en)
RU (1) RU2194051C2 (en)
UA (1) UA57758C2 (en)
WO (1) WO1998028305A1 (en)
ZA (1) ZA9711129B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2790261B1 (en) * 1999-02-26 2004-09-10 Sod Conseils Rech Applic NOVEL OPTICALLY PURE CAMPTOTHECIN ANALOGS AND PROCESSES FOR THEIR PREPARATION
US6291676B1 (en) * 1999-03-03 2001-09-18 University Of Kentucky Research Foundation Water-soluble derivatives of camptothecin/homocamptothecin
US6207832B1 (en) 1999-04-09 2001-03-27 University Of Pittsburgh Camptothecin analogs and methods of preparation thereof
AU3455100A (en) * 1999-05-28 2000-12-18 Nippon Chemiphar Co. Ltd. Process for the preparation of 2-halo-3-(3-quinolyl)propionic acid derivatives
US6372906B1 (en) 2001-04-12 2002-04-16 University Of Pittsburgh Synthesis of silyl camptothecins and silyl homocamptothecins
US6723853B2 (en) 2001-08-27 2004-04-20 University Of Pittsburgh Intermediates and methods of preparation of intermediates in the enantiomeric synthesis of (20R)homocamptothecins and the enantiomeric synthesis of (20R)homocamptothecins
US20040077674A1 (en) * 2002-03-01 2004-04-22 Curran Dennis P. Mappicine analogs, intermediates in the synthesis of mappicine analogs and methods of synthesis of mappicine analogs
ITRM20040288A1 (en) * 2004-06-11 2004-09-11 Sigma Tau Ind Farmaceuti USE OF 7-T-BUTOXYIMINOMETHYL CAMPTOTECIN FOR THE PREPARATION OF A MEDICATION FOR THE TREATMENT OF UTERUS NEOPLASIES.
EP1794127A1 (en) * 2004-09-21 2007-06-13 Société de Conseils de Recherches et d'Applications Scientifiques ( S.C.R.A.S.) Novel processes for the production of useful intermediates
CN102746314B (en) * 2011-04-18 2016-07-06 华东师范大学 Containing stablizing the camptothecine compounds of 7 yuan of lactonic rings, preparation method and purposes
CN117164601A (en) * 2022-06-02 2023-12-05 华东师范大学 High-camptothecin small molecule and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5391745A (en) * 1992-07-23 1995-02-21 Sloan-Kettering Institute For Cancer Research Methods of preparation of camptothecin analogs
CN1114608C (en) * 1995-06-21 2003-07-16 科学研究与运用咨询公司 Novel camptothecin analogues, prepn. method therefor, use thereof, and pharmaceutical compositions contg. same

Also Published As

Publication number Publication date
RU2194051C2 (en) 2002-12-10
MXPA99005776A (en) 2004-08-31
ATE248177T1 (en) 2003-09-15
AU734485B2 (en) 2001-06-14
FR2757514B1 (en) 1999-02-12
MY119473A (en) 2005-05-31
ZA9711129B (en) 1999-05-03
NZ335939A (en) 2000-04-28
PT946567E (en) 2004-01-30
NO326464B1 (en) 2008-12-08
JP3576175B2 (en) 2004-10-13
UA57758C2 (en) 2003-07-15
NO992998L (en) 1999-08-18
JP2004115535A (en) 2004-04-15
PL188181B1 (en) 2004-12-31
CA2275351C (en) 2008-10-14
CN1097056C (en) 2002-12-25
CA2275351A1 (en) 1998-07-02
NO992998D0 (en) 1999-06-18
CZ299795B6 (en) 2008-11-26
JP2001505922A (en) 2001-05-08
CN1241191A (en) 2000-01-12
CZ220599A3 (en) 1999-09-15
BR9714170A (en) 2000-02-29
PL334125A1 (en) 2000-02-14
HUP9904210A3 (en) 2000-09-28
DK0946567T3 (en) 2003-12-22
ES2206761T3 (en) 2004-05-16
KR100516874B1 (en) 2005-09-26
AU5326598A (en) 1998-07-17
DE69724453D1 (en) 2003-10-02
EP0946567A1 (en) 1999-10-06
KR20000069608A (en) 2000-11-25
DE69724453T2 (en) 2004-06-09
EP0946567B1 (en) 2003-08-27
WO1998028305A1 (en) 1998-07-02
FR2757514A1 (en) 1998-06-26
HUP9904210A2 (en) 2000-05-28
AR008543A1 (en) 2000-01-19

Similar Documents

Publication Publication Date Title
HUP0002517A3 (en) Derivatives of acyl-piperazinil-pyrimidins, preparation thereof, pharmaceutical compositions containing them and their use as medicaments
IL121236A0 (en) Cycloalkano-pyridines their preparation and pharmaceutical compositions containing them
HUP0003690A3 (en) Polymeric derivatives of camptothecins, process for their preparation and pharmaceutical compositions containing them
IL119994A0 (en) 2-oxo- and 2-thio-1,2-dihydroquinolinyl-oxazolidinones their preparation and pharmaceutical compositions containing them
IL119995A0 (en) Pyrido-fused thienyl - and furanyl-oxazolidinones their preparation and pharmaceutical compositions containing them
IL115039A (en) Spiroazabicyclic compounds, their preparation and pharmaceutical compositions containing them
GR3031526T3 (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing same
HK1017895A1 (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing same
HUP0000426A3 (en) Novel benzonaphthyridines, pharmaceutical compositions and use thereof and process for their preparation
IL125710A0 (en) Arylglycinamide derivatives their preparation and pharmaceutical compositions containing them
HUP0002272A3 (en) Aroyl-piperazine derivatives, their preparation pharmaceutical compositions containing them and their use
HUP0000664A3 (en) Azinyloxy, and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use of them for producing pharmaceutical compositions
IL118410A0 (en) Substituted camptothecin derivatives their preparation and pharmaceutical compositions containing them
IL112627A0 (en) Diketopiperazines, their preparation and pharmaceutical or veterinary compositions containing them
HUP0001385A3 (en) Pro-drugs and derivatives of camptothecin, process for their preparation, use thereof and pharmaceutical compositions containing them
ZA9557B (en) Optionally substituted phenylimidazolidines their preparation process and intermediates their use as medicaments and the pharmaceutical compositions containing them
IL117815A0 (en) Ascomycins their preparation and pharmaceutical compositions containing them
GR3033591T3 (en) Novel taxoids, preparation thereof, and pharmaceutical compositions containing same
HUP0003577A3 (en) Tetrahydro gamma-carbolines, process for their preparation, their use and pharmaceutical compositions containing them
HK1024695A1 (en) Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them
HUP9902425A3 (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing same
HU9601219D0 (en) Novel taxoids, their preparation and pharmaceutical compositions containing them
CZ92295A3 (en) Boronpeptide derivatives, process of their preparation and pharmaceutical composition containing thereof
CZ346595A3 (en) Substituted derivatives of 4-phenylthiazoles, process of their preparation and pharmaceutical compositions containing thereof
GR3034203T3 (en) Novel taxoids, preparation thereof, and pharmaceutical compositions containing same

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20111205